Walid Abushahba

Concerted action of IFN-α and IFN-λ induces local NK cell immunity and halts cancer growth

I. Castaneda, S. Kotenko, K. Reuhl, 2016, Oncotarget.

Characterization of the mouse IFN-λ ligand-receptor system: IFN-λs exhibit antitumor activity against B16 melanoma

S. Smirnov, A. Lewis-Antes, S. Kotenko, 2006 .

Characterization of the mouse IFN-lambda ligand-receptor system: IFN-lambdas exhibit antitumor activity against B16 melanoma.

S. Smirnov, A. Lewis-Antes, S. Kotenko, 2006, Cancer research.

Antitumor activity of Type I and Type III interferons in BNL hepatoma model

A. D. Torre, I. Castaneda, S. Kotenko, 2010, Cancer Immunology, Immunotherapy.

Non-Canonical Smads Phosphorylation Induced by the Glutamate Release Inhibitor, Riluzole, through GSK3 Activation in Melanoma

James S Goydos, A. Lasfar, K. Cohen-Solal, 2012, PloS one.

RUNX2 is overexpressed in melanoma cells and mediates their migration and invasion.

D. Foran, Wenjin Chen, James S Goydos, 2014, Cancer letters.

Melanoma s Exhibit Antitumor Activity against B 16 λ System : IFN-Ligand-Receptor λ Characterization of the Mouse IFN-Updated

S. Smirnov, A. Lewis-Antes, S. Kotenko, 2006 .

Interferon Lambda: A New Sword in Cancer Immunotherapy

A. Lasfar, K. Cohen-Solal, Murugabaskar Balan, 2011, Clinical & developmental immunology.